FDA warning letter
Issue date
9 Oct 2020
Issuing office
Center for Drug Evaluation and Research | CDER
Posted date
27 Oct 2020
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
Shilpa Medicare
Manufacturer
Audited
Audit report available
Warning letter
Headquarters
IndiaSites
India
Poland